|
|
| | 4-Hydroxy-2',3,3',4',5,5'-hexachlorobiphenyl Basic information |
| Product Name: | 4-Hydroxy-2',3,3',4',5,5'-hexachlorobiphenyl | | Synonyms: | 4-Hydroxy-2',3,3',5,5',6'-hexachlorobiphenyl @100 μg/mL in Isooctane;4-Hydroxy-2',3,3',4',5,5'-hexachlorobiphenyl@100 μg/mL in Isooctane;[1,1'-Biphenyl]-4-ol, 2',3,3',4',5,5'-hexachloro-;[1,1'-Biphenyl]-4-ol, 2',3,3',4',5,5'-hexachloro-;4-Hydroxy-2',3,3',4',5,5'-hexachlorobiphenyl | | CAS: | 158076-63-2 | | MF: | C12H4Cl6O | | MW: | 376.88 | | EINECS: | | | Product Categories: | | | Mol File: | 158076-63-2.mol |  |
| | 4-Hydroxy-2',3,3',4',5,5'-hexachlorobiphenyl Chemical Properties |
| | 4-Hydroxy-2',3,3',4',5,5'-hexachlorobiphenyl Usage And Synthesis |
| Uses | 2′,3,3′,4′,5,5′-Hexachloro-4-biphenylol-13C12 is 13C labeled 2′,3,3′,4′,5,5′-Hexachloro-4-biphenylol[1]. | | References | [1] Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216. DOI:10.1177/1060028018797110 |
| | 4-Hydroxy-2',3,3',4',5,5'-hexachlorobiphenyl Preparation Products And Raw materials |
|